Reducing risk in the ICU: Vascular catheter-related infections

Infections in Medicine

Volumn 23, Issue 4, 2006, Pages 141-152

  Cepkova, Magda ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacteremia; Central venous catheter related infections; Coated catheters

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; HEPARIN; MINOCYCLINE; POVIDONE IODINE; RIFAMPICIN; SULFADIAZINE SILVER; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DEVICE REMOVAL; DRUG EFFICACY; FEMORAL VEIN; FEVER; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; JUGULAR VEIN; MASK; MATERIAL COATING; MORBIDITY; MORTALITY; PNEUMOTHORAX; PROTECTIVE CLOTHING; RISK BENEFIT ANALYSIS; RISK REDUCTION; SUBCLAVIAN VEIN; THROMBOSIS;

EID: 33745605819     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control. 1998;26:522-533.
2. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32:1249-1272.
3. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142:803.
4. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286:700-707.
5. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158:81-87.
6. Mermel LA, McCormick RD. Springman SR, et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91: 197S-205S.
7. Hampton AA, Sherertz RJ. Vascular-access infections in hospitalized patients. Surg Clin North Am. 1988;68:57-71.
8. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1992;15:197-208.
9. Eyer S, Brummitt C, Crossley K, et al. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 1990;18:1073-1079.
10. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327:1062-1068.
11. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-238.
12. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med. 2000;132:641-648.
13. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32:2014-2020.
14. Cobett S, LeBlanc A. IV site infection: a prospective, randomized clinical trial comparing the efficacy of three methods of skin antisepsis. CINA: Official Journal of the Canadian Intravenous Nurses Association. 1999;15:48-50.
15. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis. 2000; 31:1001-1007.
16. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-343.
17. Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996;24: 1818-1823.
18. Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792-801.
19. McKee R, Dunsmuir R, Whitby M, et al. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect. 1985;6:419-425.
20. Ljungman P, Hagglund H, Bjorkstrand B, et al. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer. 1997;5:485-488.
21. Randolph AG, Cook DJ, Gonzales CA, et al. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest. 1998;113:165-171.
22. Hannan M, Juste RN, Umasanker S, et al. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia. 1999;54:868-872.
23. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest. 1999;115:1632-1640.
24. Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother. 1996;37:315-322.
25. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261-267.
26. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340:1-8.
27. Darouiche RO, Berger DH, Khardori N, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg. 2005;242:193-200.
28. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol. 1988;9:154-158.
29. Pemberton LB, Lyman B, Lander V, et al. Sepsis from triple- vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg. 1986;121:591-594.
30. Hilton E, Haslett TM, Borenstein MT, et al. Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med. 1988;84:667-672.
31. McCarthy MC, Shives JK, Robison RJ, et al. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. JPEN. 1987;11:259-262.
32. Clark-Christoff N, Watters VA, Sparks W, et al. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. JPEN. 1992;16:403-407.
33. Farkas JC, Liu N, Bleriot JP, et al. Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med. 1992;93:277-282.
34. Hoffmann KK, Weber DJ, Samsa GP, et al. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA. 1992;267:2072-2076.
35. Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis. 1989;159:310-319.
36. Maki DG, Stolz SS, Wheeler S, et al. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med. 1994;22:1729-1737.
37. Mermel LA. Prevention of intravascular catheter-related infections [published correction appears in Ann Intern Med. 2000;133:5]. Ann Intern Med. 2000;132:391-402.
38. Saint S, Matthay MA. Risk reduction in the intensive care unit. Am J Med. 1998;105:515-523.
39. Sheehan G, Leicht K, O'Brien M, et al. Chlorhexidine versus povidone-iodine as cutaneous antisepsis for prevention of vascular-catheter infection, In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993; Washington, DC: American Society for Microbiology; 414(a1616).
40. Meffre C, Girard R, Hajjar J, Fabry J. Is peripheral venous catheter colonization related to the antiseptic used for disinfection of the insertion site? Povidone-iodine vs. alcoholic chlorhexidine: a multicenter randomized prospective study [abstract]. Catheter Study Group. Hygienes. 1995;9:45.